CurrentHighmark Blue Cross Blue Shield WnyPolicy N/A

Autologous fat grafting to the breast — coverage criteria

Customize your policy alerts

Sign up for all Highmark Blue Cross Blue Shield Wny policy alerts

Know when Highmark Blue Cross Blue Shield Wny releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy governing use, coverage rationale, and coding guidance for autologous fat grafting (fat transfer/lipoinjection) for breast reconstruction, contour deformities, asymmetry, hypoplasia, and restoration of irradiated skin in adults.

Policy Summary

PayerHighmark Blue Cross Blue Shield Wny

PolicyAutologous fat grafting to the breast — coverage criteria

Policy CodePolicy N/A

Change TypeNo material clinical or coverage changes

Effective DateN/A

Last ReviewJun 1, 2015

Next Review DateN/A

Key ActionVerify benefits and obtain prior authorization when required; document the reconstructive indication.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Grade BStrength of recommendation

OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

CurrentHighmark Blue Cross Blue Shield WnyPolicy N/A

Autologous fat grafting to the breast — coverage criteria

Customize your policy alerts

Sign up for all Highmark Blue Cross Blue Shield Wny policy alerts

Know when Highmark Blue Cross Blue Shield Wny releases new policies or updates existing guidance.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Policy Summary

PayerHighmark Blue Cross Blue Shield Wny

PolicyAutologous fat grafting to the breast — coverage criteria

Policy CodePolicy N/A

Change TypeNo material clinical or coverage changes

Effective DateN/A

Last ReviewJun 1, 2015

Next Review DateN/A

Key ActionVerify benefits and obtain prior authorization when required; document the reconstructive indication.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Grade BStrength of recommendation

Coverage Criteria for Autologous Fat Grafting

Reconstructive Indications (Covered)

Covered when performed as reconstructive surgery to approximate normal appearance or correct deformity in the following contexts:

Primary reconstructive indications: Autologous fat grafting is considered part of reconstructive surgery when performed to approximate a normal appearance of the breasts following mastectomy or lumpectomy, to correct contour deformities after oncologic surgery, to correct breast asymmetry or hypoplasia, or to restore irradiated skin quality in the setting of breast reconstruction.

Policy endorses ASPS findings and references WHCRA requirements.

Legislative and coverage context: Breast reconstruction of the affected breast and contralateral procedures to achieve symmetry are considered reconstructive and, under the Women’s Health and Cancer Rights Act of 1998, must be covered by group health plans when performed after mastectomy.

See policy legislative summary.

Evidence summary for post-mastectomy use: Evidence (predominantly case series) provides consistent support yielding a Grade B recommendation for autologous fat grafting as an effective adjunct to breast reconstruction after mastectomy, including improvement in aesthetics and irradiated skin quality.

Supports use in post-mastectomy reconstruction.

Payer Variability (Mixed)

Coverage variability and payer stance:

Payer positions: Some major insurers consider autologous fat grafting investigational or not medically necessary and deny reimbursement; others explicitly cover fat grafting for post-mastectomy reconstruction when no native breast tissue is present or when used to fill defects after breast conservation surgery.

See insurer-specific summaries for examples.

Operational implications: Because many insurers continue to consider fat grafting not medically necessary, providers should verify benefits and obtain prior authorization where required and be prepared to offer self-pay arrangements when coverage is denied.

Document reconstructive indication consistent with WHCRA when seeking coverage.

Some payers explicitly consider autologous fat grafting to the breast as investigational and do not provide coverage. For example, certain Blue Cross Blue Shield and Cigna policy statements list autologous fat grafting (including procedures described as lipoinjection, lipofilling, lipomodelling, or with adipose‑derived stem cells) as investigational or unproven and therefore not covered by the insurer.

When an insurer classifies autologous fat grafting as experimental/investigational or not medically necessary, the procedure will be denied for coverage and the patient may be responsible for payment. Policies note that many companies continue to view fat grafting as not medically necessary and recommend that providers prepare a self‑pay package outlining procedure costs and associated care when coverage is likely to be denied.

Procedure and Diagnosis Coding

Covered CPT Codes (guideline)CPT

15771	Grafting of autologous fat harvested by liposuction technique; 50 cc or less injectate (primary)
15772	Each additional 50 cc injectate, or part thereof (add-on)

Relevant ICD-10 Diagnosis CodesICD-10

Z90.10 - Z90.13	Acquired absence of breast
N64.2	N64.2
N65.1	Breast asymmetry/disproportion of reconstructed breast
C50.011 - C50.929	Breast cancer
Q83.0 - Q83.9	Congenital malformation
N65.0	Deformity of breast
Z42.1	Encounter for breast reconstruction following
Z15.01	Genetic susceptibility to malignant neoplasm
Z85.3	Personal history of breast neoplasm
N64.82	Hypoplasia of breast

1–10 of 13

1/2

Provider Actions and Billing Guidance

Prior Authorization

Prior Authorization / Benefits Verification

Verify benefits and obtain prior authorization where required. Document the reconstructive indication (e.g., post-mastectomy reconstruction, asymmetry correction, hypoplasia, congenital deformity) in the medical record and on authorization requests to support medical necessity under the Women’s Health and Cancer Rights Act when applicable.

Check member specific benefits and plan language for coverage of autologous fat grafting
Obtain prior authorization when the payer requires it and include clinical notes, operative plan, and reconstruction indication

Denial Risk

Coverage Variability and Denial Risk

Coverage for autologous fat grafting is variable across payers; many consider it investigational or non-covered for breast procedures. Discuss potential denial risk with the patient and consider offering a self-pay option with an itemized package if coverage is denied.

Background

Autologous fat grafting (also called fat transfer, lipoinjection, lipofilling or lipomodelling) transfers non‑vascularized adipose tissue harvested from the patient to the breast to restore volume, correct contour deformities, address asymmetry or hypoplasia, and to improve irradiated skin quality following oncologic surgery. Techniques commonly involve aspiration of fat via syringe or cannula followed by processing (washing, filtering, decanting, and/or centrifugation) and reinjection into the breast as part of reconstructive treatment.

Definitions

Autologous fat grafting — definition and alternate names

TermAutologous fat grafting

Alternate namesFat transfer; lipoinjection; lipofilling; lipomodelling; fat injection

DefinitionRemoval of fat tissue from other parts of the body with placement of non-vascularized fat into subcutaneous chest tissue to rebuild or reconstruct the breast.

Reconstructive vs Cosmetic surgery — definition and distinction

Reconstructive surgery (definition)Performed on abnormal structures caused by congenital defects, developmental abnormalities, trauma, infection, tumors, or disease; generally to improve function and may approximate a normal appearance.

Distinguishing intentUse reconstructive classification when the procedure treats abnormal structure or restores form/function (e.g., post-mastectomy reconstruction); classify as cosmetic when reshaping normal tissue solely to enhance appearance.